Nicolas Fischer
Algemeen Directeur bij Berta Holding AG
Profiel
Nicolas Fischer is currently the Chief Executive Officer & Director at Coty Brasil Comércio SA and the Managing Director at Berta Holding AG.
He obtained an undergraduate degree from Technische Universität Bergakademie Freiberg.
Actieve functies van Nicolas Fischer
| Bedrijven | Functie | Begin |
|---|---|---|
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Algemeen Directeur | - |
Coty Brasil Comércio SA
 Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil. | Algemeen Directeur | - |
Opleiding van Nicolas Fischer
| Technische Universität Bergakademie Freiberg | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Coty Brasil Comércio SA
Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil. | Distribution Services |
Berta Holding AG
Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
